Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
ID: 350877Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350877

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-032.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Genomic Medicine Research (R01 Clinical Trial Optional)" aimed at stimulating innovation in the implementation of genomic information in clinical care. This initiative seeks to enhance understanding of how to effectively use and share genomic technologies, particularly focusing on populations that experience health disparities, including racial and ethnic minorities, underserved communities, and sexual and gender minority groups. With a total funding availability of approximately $3.1 million, the program encourages diverse research teams to submit proposals that include a Plan for Enhancing Diverse Perspectives (PEDP) to ensure equitable benefits from genomic advancements. Applications are due by February 12, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-HG-23-032-Full-Announcement.html
    RFA-HG-23-032.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) for "Advancing Genomic Medicine Research," aiming to stimulate innovation in implementing genomic information in clinical care. The initiative emphasizes inclusivity, urging diverse teams and perspectives in research to enhance scientific innovation and address health disparities. Key requirements include the submission of a Plan for Enhancing Diverse Perspectives (PEDP), which is essential for application acceptance. Applications may propose various projects focused on genomic medicine—encompassing implementation research, tools for analysis, and integration of genomic data into broader health systems. The funding availability includes an estimated total of $3.1 million, divided among several grants. Eligible applicants span a wide range of organizations, including higher education institutions and community-based organizations, particularly those serving underrepresented populations. The NOFO underscores the necessity for strong engagement with diverse communities and data-sharing practices to ensure that genomic advancements benefit all populations equitably, reflecting NIH's commitment to addressing health disparities while fostering research collaboration across disciplines. The deadline for submissions is set for February 12, 2025.
    Similar Opportunities
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)" aimed at supporting small-scale research projects that enhance health equity through genomic research. The initiative seeks to develop innovative approaches and metrics to ensure the equitable application of genomics in improving health outcomes for U.S. populations, particularly focusing on historically underrepresented groups in biomedical research. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofit organizations, and state governments, with funding available up to $200,000 annually for a maximum of two years. Interested parties should submit their applications by July 8, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-018.html.
    Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for a pilot program focused on Population Genomic Screening in Primary Care, designated as RFA-HG-24-021. This initiative aims to implement and evaluate screening for common genomic conditions, particularly targeting diverse populations and addressing health disparities, with a goal of enrolling approximately 5,000 patients per Clinical Group. The program emphasizes the importance of community engagement, establishing screening protocols, and ensuring follow-up care, while collaborating with a Coordinating Center and a Sequencing Center to integrate genomic screening into primary care settings. The total funding available is approximately $3.85 million, distributed across 4-5 awards over five years, with applications due by December 2, 2024. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25 Clinical Trials Not Allowed)" aimed at enhancing workforce diversity in genomics research. This initiative seeks to support educational programs that provide research experiences and skills development for individuals from diverse and underrepresented backgrounds, particularly targeting undergraduate and post-baccalaureate trainees. The program emphasizes the importance of mentorship and innovative educational strategies to foster a diverse research community, ultimately driving advancements in biomedical sciences and improving health equity. Interested applicants can find more information and submit proposals through Grants.gov, with a funding ceiling of $325,000 and a submission deadline of January 27, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the "Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)" grant, aimed at establishing a Sequencing Center to support a new population screening network. This initiative focuses on providing genomic sequencing services for 20,000 study participants, particularly targeting actionable conditions identified by the CDC, such as hereditary breast and ovarian cancer and Lynch syndrome, while ensuring inclusive recruitment from health disparity populations. The program emphasizes collaboration with community stakeholders and primary care providers to enhance genomic testing and follow-up care, ultimately aiming to integrate genomic medicine into primary care and address health disparities. Interested applicants should note that the total budget for the first year is $600,000, with escalating costs for subsequent years, and the application deadline is December 2, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-023.html.
    Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" aimed at developing informatics tools that enhance the use of a human pangenome reference as part of the Human Genome Reference Program (HGRP). The initiative seeks to fund projects that create broadly applicable tools for various sectors of genomics, including clinical and functional genomics, with a focus on improving analytical capabilities over existing methods. Up to $4 million will be allocated to support approximately six projects over a maximum period of three years, with individual project budgets capped at $400,000 annually. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for March 3, 2025.
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting research proposals focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative aims to encourage multidisciplinary research that explores various methods to address emerging ELSI questions, particularly in relation to health disparities and the implications of genomic data sharing. The NIH emphasizes the importance of including diverse perspectives in research, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application, which will be evaluated during the review process. Interested applicants, including higher education institutions and community-based organizations, can submit proposals starting January 19, 2024, with a closing date for applications set for November 18, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for a Cooperative Agreement to establish a Coordinating Center focused on population genomic screening in primary care settings. This initiative aims to evaluate and implement screening for 4-7 common genomic conditions, emphasizing community engagement and the integration of healthcare equity, particularly for underserved populations. The program, managed by the National Human Genome Research Institute (NHGRI), seeks to develop frameworks for effective genomic screening practices while adhering to NIH’s data sharing and clinical trial registration policies. Interested applicants can access the full announcement at NIH Grants, with a funding commitment of $5.75 million over five years and an application deadline of December 2, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.